_256_384.jpg)
Drug Approval | April 27, 2026
Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
The deal signals a clear push to expand access to care in underserved regions
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
The webinar series will showcase next-gen imaging technologies, global expert insights, and hands-on sessions on microscopy innovations
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
Subscribe To Our Newsletter & Stay Updated
